New Zealand researchers say that the way methotrexate currently is used may not be adequate to stop the onset of the joint damage caused by the disease.
Free Email Newsletter!
Thank you for subscribing!
Please remember to check your email to confirm your subscription. You may need to check your spam folder to find the confirmation email.